MyStart Health is a Delaware-based telehealth provider focused on GLP-1–assisted weight management. The platform connects patients with licensed clinicians for virtual consultations, prescription approval, and medication delivery. The company reports a network of over 600 board-certified doctors and promotes unlimited clinician access, medication shipping at no extra cost, and lab testing as needed.
Plans start at approximately $299 per month and are advertised under a Price-Lock Guarantee, which keeps monthly pricing stable even if dosage increases, aimed at improving cost transparency in a field often marked by hidden fees.
The process starts with an online intake form covering medical history, weight goals, and medications. A clinician reviews the information and may approve the prescription within 24 hours or arrange a same-day video consultation if needed. Once approved, the partner pharmacy fills the order and ships within two to four business days. Patients typically receive a four-week or twelve-week supply per cycle.
Monthly follow-ups ensure safe dosage titration and progress tracking. Clinicians remain accessible through the platform at all times, providing ongoing guidance and addressing potential side effects.
MyStart Health’s subscription model begins at $299 monthly, inclusive of evaluation, unlimited consultations, and medication delivery. Shipping is covered in the subscription price. No insurance is required, and payments are accepted by major credit cards such as Visa and Mastercard.
Refunds are available under specific conditions listed in the dated Refund Policy. The company honors a Price Lock Guarantee that fixes the plan’s rate for future cycles, providing budgeting certainty.
Visit MyStart Health’s official website to review current pricing, terms, and program details.
MyStart Health notes in its Important Disclosures that compounded GLP-1 medications are prepared by U.S.-licensed pharmacies under FDCA §503A and are not FDA-approved. The company also clarifies that results vary among individuals and that prescriptions are issued solely at the discretion of licensed clinicians.
On Trustpilot, MyStart averages around 4 out of 5 stars, with many users praising clear communication and prompt delivery. Some reviews mention differing dosage responses, which aligns with the individualized nature of GLP-1 therapy.
MyStart Health differentiates itself through its Price Lock Guarantee, all-inclusive plan structure, and rapid delivery timeline. The company advertises a 24/7 clinical support model, an accessible cancellation process, and a clearly documented refund policy.
The emphasis on predictable pricing and transparent medication sourcing sets the service apart from competitors in the weight loss telehealth space.
MyStart Health offers customer service Monday through Friday, from 9 a.m. to 5 p.m. EST, via phone at (888) 828-5816 or email at [email protected]. The website also provides a detailed FAQ section and an online contact form for additional inquiries.
The company’s physical address is listed as 254 Chapman Rd, Suite 209 #17801, Newark, DE 19702. Patients may cancel their plans by contacting support through phone or email and including “CANCEL” in the subject line.
Explore the Help and Support section for additional contact information and policy details.
MyStart Health offers a practical telehealth option for U.S. adults seeking GLP-1–based weight management with an emphasis on transparency and convenience. With predictable pricing, 24/7 clinician access, and included shipping, the program removes many common barriers to care. However, patients should be aware that the medications are compounded and not FDA-approved, and that MyStart operates as a private, cash-pay service rather than through insurance.
Learn more and confirm eligibility by visiting MyStart Health.
Emilia Baran, M.D., is a physician with a diverse clinical and research background and has contributed to both academic and community health settings. Dr. Baran volunteers at health clinics, works as a fact-checker for HealthDay News, and participates in multiple clinical research projects.